esource

CRIO Company News July 19, 2023 3 Minute Read

CRIO Announces Partnership with Pluto Health to Expand and Accelerate Clinical Trial Access

Innovative solution benefits patients with access to clinical trials as a treatment option, ongoing personalized health insights, and ultimately speeding new treatments to market  BOSTON, MA, July 19, 2023 – CRIO, a Boston-based healthcare technology company, in partnership with Pluto Health, a Durham, NC-based smart care coordination service company, announces the development of a scalable...

Running a Study

5 Minute Read - June 1, 2023

Progress Notes are Vital to Source Data

Progress notes are free-text entries by the investigator, coordinator or study team member that are inserted into the source record. Generally, these play a critical and highly undervalued role in the study process. Progress notes are often used to: Clarify or confirm any data points that may appear as outliers, even before a query is...

Running a Study

7 Minute Read - April 4, 2023

How eSource Replaces the EDC

Why use EDC if eSource has the endpoint data? In the CRIO article, Automate the protocol with eSource, we described how CRIO eSource automates the protocol, building compliance at the point of capture. CRIO is often asked if we can send the data to the EDC. The answer is yes, if the EDC system’s API...

Running a Study

5 Minute Read - April 3, 2023

Automate the Protocol with eSource

Hiding in plain sight – CRIO eSource is the biggest opportunity for sponsors. While the clinical research industry has automated many processes, there is one area that is still mostly paper-bound. This is the source of one of the greatest inefficiencies in research today. Automating this one process could drive 20% cost savings in a...

Running a Study

2 Minute Read - February 6, 2023

The results are in: CRAs love CRIO

Over 13,000 protocols have gone through the CRIO system, and in the vast majority of them, CRAs have used CRIO to monitor source. We’ve always heard from our sites that their CRAs love the system, but now we have proof. According to a third party survey of CRAs who have used CRIO, by a healthy...

Running a Study

4 Minute Read - January 25, 2023

CRIO sites were nearly 30% of U.S. COV19 Vaccine Sites. What this means for eSource adoption

The daunting task of COVID-19 trials The onset of the COVID-19 pandemic posed a new challenge for sponsors. They needed to execute clinical trials at a rate that has never been accomplished before. To succeed, they needed sites that could conduct the trials at unprecedented speed. These are sites with short start-up times, existing large...

Running a Study January 4, 2023 1 Minute Read

CRIO Reduces FDA Audit Risk by Over 70%

The FDA routinely audits clinical research sites, and some of those sites happened to use CRIO eSource on the studies in question. With our broad reach and history as the leading site-adopted eSource solution, we have now established a database of audit results that prove what we’ve known intuitively: CRIO eSource reduces audit risks for...

Running a Study

4 Minute Read - November 21, 2022

It’s not about DCT – Diversity Driven Clinical Trials are the Key

ASK ME ANYTHING WITH JONATHAN ANDRUS Jonathan Andrus, President & COO at CRIO, is an active thought-leader and presenter in the life sciences industry. He serves on the board and executive committee of the Society for Clinical Data Management (SCDM) and is co-lead with the Decentralized Trials and Research Alliance (DTRA) workstream initiative. In this...

Running a Study

6 Minute Read - November 16, 2022

How the World’s Leading Vaccine Site Network Decreased Protocol Deviations by Almost 40%

Overview With 9 locations in Texas, California and Louisiana, Benchmark Research is the world’s leading vaccine network. Benchmark has performed over 10,000 studies on over 40,000 subjects and has received numerous awards, including being a five-time recipient of the Best Clinical Trial Site/Network award from the World Vaccine Congress. Challenge Historically, Benchmark used paper charts...

CRIO Company News

1 Minute Read - November 3, 2022

CRIO Welcomes Dr. Margaretta Nyilas to its Board of Directors

 BOSTON, MA – November 3, 2022 – CRIO, the industry’s leading eSource provider, announces the appointment of Dr. Margaretta Nyilas to its Board of Directors, effective immediately.  Dr. Nyilas is a biopharmaceutical executive with over twenty years of diverse global industry experience, formerly at Otsuka Pharmaceuticals, Bristol Myers Squibb and Click Therapeutics. She has a...

Running a Study

3 Minute Read - October 28, 2022

Direct Data Access versus Open API

Bala Nair is the Enterprise Architect at CRIO. With over 20 years of experience in the technology industry, Bala has shaped several cutting-edge engineering developments, from AOL’s Instant Messenger, to building software that delivered over 50% of video on demand content to U.S. households. At CRIO, Bala partners with other strategic owners to manage CRIO’s...

Running a Study

9 Minute Read - October 6, 2022

Leveraging eSource as a Study Manager for Remote Monitoring

Increased efficiencies Despite the myriad of additional issues caused by COVID, our study team’s efficiency dramatically increased with remote monitoring. I have long been a proponent of the potential of eSource and its advantages in clinical trials. From my experience as a CRA (Clinical Research Associate) I first wrote about eSource in November 2018, SOCRA...